Censa Pharmaceuticals Overview
- Founded
- 2015

- Status
- Acquired/Merged
- Employees
- 7

- Latest Deal Type
- M&A
- Latest Deal Amount
- $539M

Censa Pharmaceuticals General Information
Description
Developer of bio-medical therapeutics designed to treat (ultra) orphan CNS disorders. The company's therapeutics treat orphan metabolic diseases with earlier stage programs targeting central nervous system diseases, disorders of neurotransmitter degradation and synthesis, enabling patients to recover debilitating diseases.
Contact Information
(Operating Subsidiary)
- 65 William Street
- Suite 200
- Wellesley, MA 02481
- United States
Censa Pharmaceuticals Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Merger/Acquisition | 29-May-2020 | $539M | 00.000 | 00000 | Completed | Clinical Trials - Phase 3 |
3. Merger/Acquisition | 05-Jan-2018 | 0000 | 0000 | Cancelled | Startup | |
2. Early Stage VC | 21-Nov-2017 | $1.5M | $3.01M | Completed | Startup | |
1. Angel (individual) | 19-Apr-2016 | $1.51M | $1.51M | 000.00 | Completed | Startup |
Censa Pharmaceuticals Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A | 000,000 | 00.000000 | 00 | 00 | 00 | 00 | 00 | 0.000 |
Censa Pharmaceuticals Comparisons
Industry
00000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialCensa Pharmaceuticals Competitors (1)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
00000000 000000000 | Formerly PE-Backed | San Rafael, CA | 0000 | 00000 | 0000 | 00000 |
Censa Pharmaceuticals Executive Team (2)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Johnathan Reis MD | President & Chief Executive Officer | ||
Christopher Schelling | Founder |
Censa Pharmaceuticals Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialCensa Pharmaceuticals Former Investors (2)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Arkin Holdings | PE/Buyout | Minority | 000 0000 | 000000 0 | |
InClin | Other | Minority | 000 0000 | 000000 0 |